NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

Sounds very much like NWBO and Advent are maintaining control of the leukapheresis business for DCVax-L. They might as well keep it in house since they will need quite a bit of leuapheresis to be conducted on each and every patient. And they did all the work of finding sites for it. I wonder how many sites they have around the UK?
According to the job dscription:

Job Summary
Based in London, the purpose of this role is to lead the quality management system and governance of an apheresis clinic in London. The successful candidate will work within a fast-paced multidisciplinary HTA/ GxP / GMP environment ensuring all documentation and information is processed in line with these requirements.
?

Application acceptance closes on March 13, 2026.
Another short runway.
The company seems in a hurry to fill key positions.
Thanks again, Stockafella.